Zai Lab
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zai Lab and other ETFs, options, and stocks.About ZLAB
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra.
ZLAB Key Statistics
Stock Snapshot
As of today, Zai Lab(ZLAB) shares are valued at $17.79. The company's market cap stands at 1.98B, with a P/E ratio of -9.12.
During the trading session on 2025-12-13, Zai Lab(ZLAB) shares reached a daily high of $18.66 and a low of $17.70. At a current price of $17.79, the stock is +0.5% higher than the low and still -4.7% under the high.
Trading volume for Zai Lab(ZLAB) stock has reached 852.65K, versus its average volume of 776.98K.
Over the past 52 weeks, Zai Lab(ZLAB) stock has traded between a high of $44.34 and a low of $17.70.
Over the past 52 weeks, Zai Lab(ZLAB) stock has traded between a high of $44.34 and a low of $17.70.
ZLAB News
Zai Lab Limited recently dosed the first participant in a global Phase 1/1b trial of ZL-1503, its internally discovered IL-13/IL-31R bispecific antibody for mod...
Zai Lab (ZLAB) announced the dosing of the first participant in a global Phase 1/1b clinical trial evaluating the safety, tolerability, pharmacokinetics, and ef...